Daily SPAC Update – February 17, 2026

by | Feb 17, 2026

Relativity Acquisition Extension Approved. Churchill Capital X DeSPAC Trades as Infleqtion (INFQ) Today.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

DAILY SPAC UPDATE

SPAC VOTE RESULTS
RACY – RELATIVITY ACQUISITION CORP * Extend to Feb 15, 2027 * 6,587 redeemed * $84,116 removed * trust $12.77

DeSPACs
Feb 17: CCCX DeSPAC to Infleqtion (INFQ)

About Infleqtion
Infleqtion is a global leader in neutral-atom quantum technology. We design and build quantum computers, precision sensors, and quantum software for governments, enterprises, and research institutions. Our commercial portfolio includes quantum computers as well as quantum RF systems, quantum clocks, and inertial navigation solutions. Infleqtion is the partner of choice for governments and commercial customers seeking cutting-edge quantum capabilities.

SPAC EXECUTIVE / DIRECTOR MOVES

Company Ticker Moves
Proem Acquisition Corp. I
  • On February 11, 2026, four independent directors, John Wu, David Eckstein, Amarnath Thombre, and Andrey Kazakov, were appointed to the board of directors and assigned to various committee roles.  (view source)

NEW SPAC IPOs
Feb 13: WLII – Willow Lane Acquisition Corp. II $125M IPO
Feb 13: RFAM – Rf Acquisition Corp III $100M IPO
Feb 12: XFLH – Xflh Capital Corp $100M IPO
Feb 12: PAAC – Proem Acquisition Corp. I $130M IPO
Feb 12: HACQ – Hcm Iv Acquisition Corp. $250M IPO
Feb 11: IACO – Idea Acquisition Corp. $350M IPO
Feb 11: CMII – Columbus Circle Capital Corp II $200M IPO (+underwriter overallotment: $30M)
Feb 11: DBCA – D. Boral Acquisition I Corp. $250M IPO
Feb 11: TMTS – Spartacus Acquisition Corp. II $200M IPO
Feb 10: SVIV – Spring Valley Acquisition Corp. IV $200M IPO (+underwriter overallotment: $30M)

SPAC MOVERS

YESTERDAY’S TOP SPAC GAINERS
10.7% ~ $ 12.71 | HSPT – HORIZON SPACE ACQUISITION II CORP (Announced)
5.7% ~ $ 6.17 | RDAC – RISING DRAGON ACQUISITION CORP (Announced)
3.4% ~ $ 11.53 | CEPT – CANTOR EQUITY PARTNERS II INC (Announced)
1.3% ~ $ 12.34 | ESHA – ESH ACQUISITION CORP (Announced)
1.1% ~ $ 11.36 | AEXA – AMERICAN EXCEPTIONALISM ACQUISITION CORP A (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-3.6% ~ $ 11.24 | TBMC – TRAILBLAZER MERGER CORP I (Announced)
-1.1% ~ $ 13.91 | PCSC – PERCEPTIVE CAPITAL SOLUTIONS CORP (Pre-Deal)
-.6% ~ $ 48.00 | AFJK – AIMEI HEALTH TECHNOLOGY CO LTD (Announced)
-.6% ~ $ 9.97 | RNGT – RANGE CAPITAL ACQUISITION CORP II (Pre-Deal)
-.5% ~ $ 9.94 | IGAC – INVEST GREEN ACQUISITION CORP (Pre-Deal)

Recent Analysis

Daily SPAC Update – February 13, 2026

RF Acquisition III and Willow Lane II IPO. Goal Acquisitions and Inception Growth SPAC Extensions Approved. Haymaker 4 and Inflection Point IV Set Deal Votes for March. Aura Fat Projects LOI.

Daily SPAC Update – February 12, 2026

XFLH Capital, Proem Acquistion, and HCM IV IPO to Make it 15 for February. Inception Growth Extension Approved. Churchill Capital + Infleqtion and Horizon Space II + SL Bio Deal Votes.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.